Past Newsletters
News
Telehealth Referral Leads to Diagnosis and Effective Treatment of Rare Neuropathy: Case Study
A 68-year-old man from Hawaii with acetylcholine receptor (AChR) antibody–positive myasthenia gravis and poorly controlled type 2 diabetes complicated by neuropathy had been receiving intravenous immunoglobulin (IVIg) and taking pyridostigmine ...
News
Researchers Identify New Glucose Control Target That Could Lead to Novel Therapeutic Approaches
A 2017 study co-led by UCSF researchers found that a high-fat diet (HFD) is associated with the accumulation of inflammatory cells called microglia in the hypothalamus, which in turn increases the susceptibility of mice to overeat and gain excess weight.
News
Why Do Some Long Covid Patients Continue to Have Difficulty Exercising?
While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.
News
Can What Works to Treat Cancer Work for Diabetes?
To live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only treatment, subcutaneous insulin, is burdensome...
News
A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler
There is a major clinical unmet need for effective and safe therapies to increase progression-free and overall survival in older individuals with leukemia whose prognosis is grim.
News
Robotically Assisted, Completely Minimally Invasive Whipple Surgery: Case Study With Video
Since performing San Francisco’s first pure robotically assisted Whipple procedure in 2022, UCSF surgeons continue to be on the forefront of this technology, regularly performing robotic Whipple surgeries (pancreatoduodenectomies) on select patients.
News
UCSF Health Performs 150th Robotic Focal HIFU Procedure
UCSF is West Coast leader for the innovative, minimally invasive treatment for prostate cancer patients.
News
New Research on Optimizing UC Management Through Patient-Centered Tofacitinib Dosing
Tofacitinib is effective for managing ulcerative colitis (UC) and is linked to sustained steroid-free remission. The product label recommends dose de-escalation after eight or 16 weeks, but is this best for patients?
News
Deadly Dust: Engineered Stone Is Making California Workers Sick
Workers making artificial-stone slabs for the most popular type of countertops sold in the United States are developing a potentially deadly, irreversible lung disease from tiny particles of toxic dust, researchers from UC San Francisco and UCLA found...
News
Millions of Long-Term Smokers Have Lung Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those, chronic obstructive pulmonary disease (COPD)...
News
Novel Intraoperative Prostate Cancer Imaging Method Reveals Previously Undetectable Disease
UCSF researchers led the first-in-human study of a novel near-infrared fluorescence imaging agent that targets prostate-specific membrane antigen (PSMA).
News
The UCSF cancer program has been continuously accredited by the CoC since 1933, demonstrating its commitment to the best outcomes possible for its cancer patients.
News
UCSF Among First in U.S. to Receive New Surgery Designation from the American College of Surgeons
UC San Francisco Medical Center (UCSF) is among just four hospitals in the U.S. to be verified as part of the American College of Surgeons (ACS) Vascular Verification Program (Vascular-VP)...
News
A UC San Francisco (UCSF)-led study of patients with chronic kidney disease (CKD) has found that mild-to-moderate acute kidney injury (AKI) did not predict worsening of kidney function after taking into account differences in pre-existing health.
News
Does Hydrocortisone Improve Treatment of Septic Shock?
Sepsis is a global health priority affecting 55 million patients worldwide and causing 11 million deaths annually.
